One chemokine with well-documented proatherogenic properties is MCP-1, whose levels are elevated in patients with conditions such as hypertension, obesity, and atherosclerosis [8,9]. This evidence concerns the gene CCL2 and obesity due to melanocortin 4 receptor deficiency.